Deferasirox (Exjade) significantly improves cardiac T2* in heavily iron-overloaded patients with beta-thalassemia major.

Ann Hematol · 2010 · PMC2824843 · PMID 19798501

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

When data were analyzed by baseline T2* subgroup, the reduction in these markers of total body iron did not reach statistical significance in the <10-ms and 10–20-ms subgroups.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.